Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.
作者信息
Wernette Catherine M, Frasch Carl E, Madore Dace, Carlone George, Goldblatt David, Plikaytis Brian, Benjamin William, Quataert Sally A, Hildreth Steve, Sikkema Daniel J, Käyhty Helena, Jonsdottir Ingileif, Nahm Moon H
机构信息
Department of Pathology and Microbiology, University of Alabama at Birmingham, Birmingham, Alabama 35249-7331, USA.
出版信息
Clin Diagn Lab Immunol. 2003 Jul;10(4):514-9. doi: 10.1128/cdli.10.4.514-519.2003.
Abstract
摘要
相似文献
1
Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.
Clin Diagn Lab Immunol. 2003 Jul;10(4):514-9. doi: 10.1128/cdli.10.4.514-519.2003.
2
3
Comparison between a new multiplex electrochemiluminescence assay and the WHO reference enzyme-linked immunosorbent assay to measure serum antibodies against pneumococcal serotype-specific polysaccharides.
Vaccine. 2019 Apr 10;37(16):2208-2215. doi: 10.1016/j.vaccine.2019.03.011. Epub 2019 Mar 15.
4
Enzyme-linked immunosorbent assay for measuring antibodies to pneumococcal polysaccharides for the PNEUMOVAX 23 vaccine: assay operating characteristics and correlation to the WHO international assay.
Clin Vaccine Immunol. 2006 Aug;13(8):905-12. doi: 10.1128/CVI.00014-06.
5
Re.: Anti-pneumococcal polysaccharide ELISA.
J Immunol Methods. 1986 Apr 17;88(2):285-6. doi: 10.1016/0022-1759(86)90017-7.
6
Immunoglobulin G and M antibodies to pneumococcal polysaccharides detected by enzyme-linked immunosorbent assay.
Infect Immun. 1980 Feb;27(2):411-7. doi: 10.1128/iai.27.2.411-417.1980.
7
Comparison of an enzyme-linked immunosorbent assay with radioimmunoassay for the measurement of pneumococcal capsular polysaccharide antibodies.
Mol Immunol. 1985 Mar;22(3):313-9. doi: 10.1016/0161-5890(85)90167-1.
8
Enzyme-linked immunosorbent assay for measurement of antibodies against pneumococcal polysaccharide antigens: comparison with radioimmunoassay.
J Clin Microbiol. 1979 Oct;10(4):459-63. doi: 10.1128/jcm.10.4.459-463.1979.
9
Development and Validation of 13-plex Luminex-Based Assay for Measuring Human Serum Antibodies to Capsular Polysaccharides.
mSphere. 2018 Aug 8;3(4):e00128-18. doi: 10.1128/mSphere.00128-18.
10
ELISA determination of IgG antibodies to pneumococcal capsular polysaccharides in a group of children.
J Immunol Methods. 1987 Nov 23;104(1-2):143-8. doi: 10.1016/0022-1759(87)90498-4.
引用本文的文献
1
Immunogenicity, safety and adverse events of sequential vaccination with a 10-valent pneumococcal conjugate vaccine (PCV10) and PPSV23 compared with PPSV23 alone in systemic lupus erythematosus.
Lupus Sci Med. 2025 Sep 8;12(2):e001551. doi: 10.1136/lupus-2025-001551.
2
Quantitative Methods for Evaluating Antibody Responses to Pneumococcal Vaccines: A Scoping Review.
Trop Med Infect Dis. 2025 Aug 21;10(8):236. doi: 10.3390/tropicalmed10080236.
3
Approaches to assess new pneumococcal vaccines for immunogenicity, development and licensure.
Hum Vaccin Immunother. 2025 Dec;21(1):2545032. doi: 10.1080/21645515.2025.2545032. Epub 2025 Aug 13.
4
Evaluation of a Multiplex Electrochemiluminescence Assay for Detection of Anti-Pneumococcal Antibodies in the Diagnosis of Selective Polysaccharide Antibody Deficiency.
J Clin Immunol. 2025 Jul 10;45(1):112. doi: 10.1007/s10875-025-01911-0.
5
Immunogenicity and safety of a multi-human dose formulation of Biological E's 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14) administered to 6-8-week-old healthy infants: a phase 3, single-blind, randomized, active-controlled study.
Front Immunol. 2025 Apr 7;16:1550227. doi: 10.3389/fimmu.2025.1550227. eCollection 2025.
6
Diagnosis, Characteristics, and Outcome of Selective Anti-polysaccharide Antibody Deficiencies In A Retrospective Cohort of 55 Adult Patients.
J Clin Immunol. 2025 Mar 17;45(1):82. doi: 10.1007/s10875-025-01874-2.
7
Establishing a new human pneumococcal standard reference serum, MPRSS-01.
mSphere. 2025 Jan 28;10(1):e0040424. doi: 10.1128/msphere.00404-24. Epub 2025 Jan 7.
8
Clinical features and immune memory of breakthrough infection in children after age-appropriate 13-valent pneumococcal conjugate vaccination in Taiwan.
Infection. 2024 Nov 5. doi: 10.1007/s15010-024-02426-3.
9
Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development.
Vaccines (Basel). 2024 Aug 28;12(9):974. doi: 10.3390/vaccines12090974.
10
Development and validation of carbodiimide-activated ELISA plate for quantifying IgG levels against capsular polysaccharides.
Bioanalysis. 2024;16(13):641-650. doi: 10.1080/17576180.2024.2349453. Epub 2024 Jun 10.
本文引用的文献
1
THE PROTECTIVE ACTION OF A SPECIFIC ENZYME AGAINST TYPE III PNEUMOCOCCUS INFECTION IN MICE.
J Exp Med. 1931 Jun 30;54(1):73-89. doi: 10.1084/jem.54.1.73.
2
Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.
Vaccine. 2003 Jul 4;21(23):3265-72. doi: 10.1016/s0264-410x(03)00230-5.
3
Vaccination of COPD patients with a pneumococcus type 6B tetanus toxoid conjugate vaccine.
Eur Respir J. 2002 Oct;20(4):813-8. doi: 10.1183/09031936.02.00289702.
4
Effect of monophosphoryl lipid A (MPL) on T-helper cells when administered as an adjuvant with pneumocococcal-CRM197 conjugate vaccine in healthy toddlers.
Vaccine. 2002 Nov 1;20(31-32):3658-67. doi: 10.1016/s0264-410x(02)00413-9.
5
Antibody response to an eleven valent diphtheria- and tetanus-conjugated pneumococcal conjugate vaccine in Filipino infants.
Pediatr Infect Dis J. 2002 Apr;21(4):309-14. doi: 10.1097/00006454-200204000-00010.
6
Development and evaluation of pneumococcal conjugate vaccines: clinical trials and control tests.
Crit Rev Microbiol. 2002;28(1):27-41. doi: 10.1080/1040-840291046678.
7
Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice.
Infect Immun. 2002 Mar;70(3):1443-52. doi: 10.1128/IAI.70.3.1443-1452.2002.
8
Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant.
J Infect Dis. 2001 Nov 1;184(9):1211-5. doi: 10.1086/323648. Epub 2001 Sep 25.
9
Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay.
Clin Diagn Lab Immunol. 2001 Mar;8(2):266-72. doi: 10.1128/CDLI.8.2.266-272.2001.
10
Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B.
Infect Immun. 2001 Jan;69(1):336-44. doi: 10.1128/IAI.69.1.336-344.2001.
Zotero 插件